Harnessing microbubbles for the targeted delivery of genetic medicines to a wide range of human organs.
SonoThera is developing an ultrasound-guided nonviral gene therapy platform and therapies to provide patients with the next generation of genetic medicines.
SonoThera’s technology platform aims to overcome the most significant barriers in gene therapy such as safety, efficacy, biodistribution, and high costs of goods.